These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Outcomes in glycemic control in the intermediate follow-up of Roux-en-Y gastric bypass: a Brazilian cohort study.
    Author: Beleigoli AM, Coelho AL, Diniz MT, Lages Savassi-Rocha A, Diniz Mde F.
    Journal: Surg Obes Relat Dis; 2014; 10(6):1022-7. PubMed ID: 25445150.
    Abstract:
    BACKGROUND: It is not widely known whether glycemic control (GC) is sustained after Roux-en-Y gastric bypass (RYGB). The objective of this study was to investigate incidence and remission of type 2 diabetes mellitus (T2DM) among 284 individuals with body mass index (BMI)≥35 kg/m(2) at operation (1998-2011) through 2013. METHODS: Baseline GC was based on fasting glycemia (FG), hemoglobin A1c (HbA1c), and medication. Incident T2DM, complete (normal GC/HbA1c) and partial (abnormal FG/A1c) remission at the last follow-up visit, and relapse were the outcomes of interest. Kaplan-Meier curves and log-rank tests were used to compare time to improvement according to insulin use and HbA1c levels at baseline. Pre- and postoperative determinants of T2DM improvement were investigated by logistic regression. RESULTS: Participants were predominantly female (220; 77.2%) with mean age of 39.6 (10.5) years and median BMI of 51.9 (46.1-57.5) kg/m(2) at operation. The mean follow-up time was 5.1 (3.2) years with 67.5% (55.0-78.4) of excess BMI loss (EBL) at the 5(th) year. Normal GC, abnormal FG, and T2DM were observed in 169 (59.5%), 32 (11.2%), and 83 (29.3%) participants at baseline, respectively. The 7 (4.1%) patients with incident T2DM had lower BMI at baseline than those who remained with normal GC (43.6 kg/m(2) [42.0-50.8] versus 52.1 kg/m(2) [46.7-57.7]; P = .01). Complete and partial T2DM remission occurred in 61 (61.3%) and 5 (6.7%) participants, respectively. Baseline HbA1c was associated with a significant difference in the proportion of cases with remission at the 5(th) year of follow-up (P = .016). Age (OR .83; 95% CI .72-.95) and % EBL at the 2(nd) year of follow-up (OR 1.05; 95% CI 1.01-1.09) were independent determinants of T2DM improvement. Relapse occurred in 14 (14.3%) cases. CONCLUSION: We observed a low incidence and impressive improvement rates of T2DM after intermediate follow-up of RYGB.
    [Abstract] [Full Text] [Related] [New Search]